Penta Valent
PT. Penta Valent Tbk distributes pharmaceutical products, medical equipment, and consumer products in Indonesia. It operates through Pharmaceutical Products and Consumer Goods segments. The company offers prescription medicinal products; over the counter drug products; medical supporting equipment, such as blood pressure meters, body thermometers, and others; reaction materials, such as blood sug… Read more
Penta Valent (PEVE) - Total Liabilities
Latest total liabilities as of September 2025: Rp983.83 Billion IDR
Based on the latest financial reports, Penta Valent (PEVE) has total liabilities worth Rp983.83 Billion IDR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Penta Valent - Total Liabilities Trend (2022–2024)
This chart illustrates how Penta Valent's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Penta Valent Competitors by Total Liabilities
The table below lists competitors of Penta Valent ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tecnisa S.A
SA:TCSA3
|
Brazil | R$782.62 Million |
|
OVB Holding AG
XETRA:O4B
|
Germany | €200.87 Million |
|
Aiptek International Inc
TW:6225
|
Taiwan | NT$14.51 Million |
|
068100
KQ:068100
|
Korea | ₩5.97 Billion |
|
GCM Resources Plc
PINK:GCLMF
|
USA | $7.58 Million |
|
Manaksia Steels Limited
NSE:MANAKSTEEL
|
India | ₹2.64 Billion |
|
Xreality Group Ltd
AU:XRG
|
Australia | AU$33.77 Million |
Liability Composition Analysis (2022–2024)
This chart breaks down Penta Valent's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.97 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Penta Valent's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Penta Valent (2022–2024)
The table below shows the annual total liabilities of Penta Valent from 2022 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp876.52 Billion | +29.95% |
| 2023-12-31 | Rp674.53 Billion | +12.96% |
| 2022-12-31 | Rp597.16 Billion | -- |